All Jiangsu Hansoh Pharmaceutical Group Co., Ltd articles

News

Effectiveness and safety of tenofovir amibufenamide in the treatment of chronic hepatitis B: A real-world, multicenter study

2025-01-20T10:30:00Z

A new study aimed to evaluate the real-world effectiveness and safety of tenofovir amibufenamide (TMF) in a cohort of patients with chronic hepatitis B (CHB).